Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized phase II study of single-agent epirubicin +/- verapamil in patients with advanced metastatic breast cancer. An AIO clinical trial. Arbeitsgemeinschaft Internistische Onkologie of the German Cancer Society.
Mross K, Bohn C, Edler L, Jonat W, Queisser W, Heidemann E, Goebel M, Hossfeld DK. Mross K, et al. Among authors: queisser w. Ann Oncol. 1993 Jan;4(1):45-50. doi: 10.1093/oxfordjournals.annonc.a058356. Ann Oncol. 1993. PMID: 8435362 Free article. Clinical Trial.
Prognostic factors of advanced colorectal cancer patients.
Edler L, Heim ME, Quintero C, Brummer T, Queisser W. Edler L, et al. Among authors: queisser w. Eur J Cancer Clin Oncol. 1986 Oct;22(10):1231-7. doi: 10.1016/0277-5379(86)90325-1. Eur J Cancer Clin Oncol. 1986. PMID: 3816914
Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society.
Hartung G, Stehle G, Sinn H, Wunder A, Schrenk HH, Heeger S, Kränzle M, Edler L, Frei E, Fiebig HH, Heene DL, Maier-Borst W, Queisser W. Hartung G, et al. Among authors: queisser w. Clin Cancer Res. 1999 Apr;5(4):753-9. Clin Cancer Res. 1999. PMID: 10213209 Clinical Trial.
Combination chemotherapy (VAC/FMC) with immunostimulation in metastatic breast cancer: a randomized study comparing different times and routes of administration of Corynebacterium parvum.
Fritze D, Massner B, Becher R, Kaufmann M, Illiger HJ, Hartlapp J, Queisser W, Abel U, Edler L, Mayr AC, et al. Fritze D, et al. Among authors: queisser w. Klin Wochenschr. 1984 Feb 15;62(4):162-7. doi: 10.1007/BF01731638. Klin Wochenschr. 1984. PMID: 6368960 Clinical Trial.
133 results